Inj., emapalumab-lzsg, 1 mg
Products billed under this code include Gamifant.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9210
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gamifant | Swedish Orphan Biovitrum AB (PuBL) | 66658-0501-01 | 10 | $3,918.61 |
| Gamifant | Swedish Orphan Biovitrum AB (PuBL) | 66658-0505-01 | 50 | $19,593.05 |
| Gamifant | Swedish Orphan Biovitrum AB (PuBL) | 66658-0510-01 | 100 | $39,186.10 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $391.861 | −$0.919 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $392.78 | +$8.645 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $384.135 | +$0.003 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted September 15, 2026 |
| 1Q26 | $384.132 | −$0.716 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted September 15, 2026 |
| 4Q25 | $384.848 | +$3.208 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted September 8, 2026 |
| 3Q25 | $381.64 | +$0.137 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted March 10, 2026 |
| 2Q25 | $381.503 | +$4.934 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted March 10, 2026 |
| 1Q25 | $376.569 | −$1.46 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted December 19, 2025 |
| 4Q24 | $378.029 | +$11.359 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 11, 2025 |
| 3Q24 | $366.67 | +$1.797 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 11, 2025 |
| 2Q24 | $364.873 | −$10.784 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted March 11, 2025 |
| 1Q24 | $375.657 | −$14.501 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted December 19, 2024 |
| 4Q23 | $390.158 | −$3.565 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted October 10, 2024 |
| 3Q23 | $393.723 | +$15.608 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 5, 2024 |
| 2Q23 | $378.115 | −$13.20 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted February 23, 2024 |
| 1Q23 | $391.315 | +$15.601 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted December 6, 2023 |
| 4Q22 | $375.714 | −$4.675 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 22, 2023 |
| 3Q22 | $380.389 | +$15.398 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 9, 2023 |
| 2Q22 | $364.991 | +$2.678 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted December 14, 2022 |
| 1Q22 | $362.313 | −$13.72 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 8, 2022 |
| 4Q21 | $376.033 | −$13.853 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 2, 2022 |
| 3Q21 | $389.886 | +$15.863 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted June 2, 2022 |
| 2Q21 | $374.023 | −$19.136 | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted March 1, 2022 |
| 1Q21 | $393.159 | – | 1 MG | Inj., emapalumab-lzsg, 1 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021